Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds targeting central nervous system disorders. Shows potential in the development of novel therapeutics for anxiety and depression due to its structural affinity for modulating neurotransmitter receptors. Also employed in the design of selective kinase inhibitors for oncology applications. Its spirocyclic framework enhances metabolic stability, making it valuable in optimizing drug candidates for improved pharmacokinetics.